Details for Australian Trade Mark No. 1048780 (hide)

Owner Celgene Corporation a Delaware Corporation

Convention US 14 FEBRUARY 2005 76/631,209

Service Banki Haddock Fiora Lawyers Level **** Street SYDNEY NSW 2000

Various Convention priority claimed: 14 February 2005, United States of America, No. 76/631,209 in respect of PHARMACEUTICAL PREPARATIONS NAMELY CYTOKINE INHIBITORY DRUGS; PHARMACEUTICAL PREPARATIONS THAT MODULATE THE IMMUNE SYSTEM. The trade mark consists of th

Filing Date 1 April 2005

Classes

Class 5 Pharmaceutical preparations including cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Event Publications

21 April 2005 Application filed

16 June 2005 Application Accepted

16 June 2005 Trade Mark Removed from the Register / IR Expired

13 October 2005 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1048781-skinscan

1048779